Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients?: A systematic review and meta-analysis
Critical Care | Aug 11, 2017
Zhu Y, et al. – Efficacy and safety of remifentanil versus other opioids in mechanically ventilated patients, were assessed. Findings indicated that duration of mechanical ventilation, time to extubation after cessation of sedation, and length of ICU stay (ICU-LOS) appeared to be reduced in association with remifentanil use. In addition, hospital–LOS, costs, mortality or agitation offered by remifentanil versus other opioids did not vary significantly.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries